Group 1 - The company has announced a change in the continuous supervision representative for its initial public offering (IPO) project due to the work relocation of the previous representative, Lu Danjun [1][2] - CITIC Securities, as the sponsor and continuous supervision institution, will continue to fulfill its supervisory responsibilities until the raised funds are fully utilized, which is expected to be by December 31, 2023 [1][2] - The company expresses gratitude to Lu Danjun for his contributions during the IPO and continuous supervision period [3] Group 2 - Shao Luwei has been appointed as the new continuous supervision representative, taking over from Lu Danjun [2] - The current continuous supervision representatives for the IPO project are Sun Dong and Shao Luwei [2] - Shao Luwei holds a master's degree and has participated in various IPO projects, including those of Yunzhongma and Jinchun Co., among others [4]
北京天智航医疗科技股份有限公司 关于变更持续督导保荐代表人的公告